Malaysia to buy more Pfizer-BioNTech vaccines

KUALA LUMPUR (Reuters) - Malaysia will buy additional doses of Pfizer-BioNTech’s COVID-19 vaccine, bringing the total secured to 32 million, enough to cover half of its population, the country’s science minister said on Monday. The Southeast Asian country last month embarked on a nationwide vaccination programme, targeting to inoculate 80% of its 32 million people by February 2022.
Read more...

;